The introduction of pneumococcal conjugate vaccine may change the epidemiology of Streptococcus pneumoniae. The increased prevalence of non-vaccine serotypes as the cause of pneumococcal diseases has already reported in the United States and Europe. However, little attention has been focused on the S. pneumoniae. In this study, nonencapsulated S. pneumoniae were identified in 15 isolates (6.4%) out of 236 pneumococcal strains obtained from the nasopharynges of children with acute otitis media (AOM), in 3 isolates (14.3%) out of 21 strains from acute rhinosinusitis, and in 2 isolates (12.5%) out of 16 nasopharyngeal carriage strains obtained from normal healthy children. Among the 20 nonencapsulated S. pneumoniae isolates, 15 (75.0%) isolates had the pspK gene. Seven sequence types (STs) were identified: ST7502 (5 strains), ST1106 (2 strains), ST7803 (2 strains), ST7786 (1 strain), ST6741 (1 strain), ST7496 (1 strain), and ST8642 (1 strain). Because nonencapsulated S. pneumoniae strains are not targeted by the current available pneumococcal vaccines, these strains will gradually become more common in nasopharyngeal carriage. The increase in colonization and dissemination of these strains would increase the risk of AOM and other systemic pneumococcal diseases against which current vaccines cannot provide protection. Nonencapsulated S. pneumoniae may thus become more prevalent as human pathogen.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jiac.2015.10.006 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Protection induced by Streptococcus pneumoniae extracellular vesicles against nasal colonization and invasive infection in mice and the role of PspA.
Vaccine
January 2025
Laboratório de Bacteriologia, Instituto Butantan, São Paulo, SP, Brazil. Electronic address:
Diseases caused by Streptococcus pneumoniae (pneumococcus) produce a great impact on public health, killing about one million people annually despite available vaccines. Recent research has revealed that the pneumococcus produces extracellular vesicles (pEVs), which display selective cargo and hold potential for vaccine development. Here, we evaluated the immunogenicity and protective potential of pEVs derived from a non-encapsulated pneumococcal strain (R6) using murine models of pneumococcal colonization and invasive pneumonia.
View Article and Find Full Text PDFSerotype distribution and antimicrobial resistance of isolated from children in Japan, 2023.
New Microbes New Infect
December 2024
Department of Hygiene, Sapporo Medical University School of Medicine, Sapporo, Japan.
Background: The prevalence of serotypes and antimicrobial resistance of was characterized among children thirteen years after the licensure of the pneumococcal conjugate vaccine (PCV) in Japan.
Methods: A total of 353 pneumococcal isolates were collected from Japanese children between March and July 2023. All the isolates were serotyped using genetic methods and tested for susceptibility to 14 antimicrobial agents.
Cytokine secretion by in vitro cultures of lung epithelial cells, differentiated macrophages and differentiated dendritic cells incubated with pneumococci and pneumococcal extracellular vesicles.
Braz J Microbiol
December 2024
Laboratório de Bacteriologia, Instituto Butantan, Av Vital Brasil 1500, São Paulo, SP, 05503-900, Brazil.
Streptococcus pneumoniae is an important human pathogen that can colonize the respiratory tract of healthy individuals. The respiratory tract mucosa is thus the first barrier for this pathogen. In this study, we have tested three models of the respiratory epithelium with immune cells: (i) monolayer of A549 human lung epithelial cells, (ii) A549 + macrophages differentiated from the human monocytic THP-1 cell line (dMφ) and (iii) A549 + dMφ + dendritic cells differentiated from THP-1 (dDC) using a two-chamber system.
View Article and Find Full Text PDFUltrastructural, metabolic and genetic characteristics of determinants facilitating the acquisition of macrolide resistance by Streptococcus pneumoniae.
Drug Resist Updat
November 2024
Department of Cell and Molecular Biology, University of Mississippi Medical Center, Jackson, MS 39216, United States; Center for Immunology and Microbial Research, University of Mississippi Medical Center, Jackson, MS 39216, United States. Electronic address:
Aims: To investigate the molecular events associated with acquiring macrolide resistance genes [mefE/mel (Mega) or ermB] in Streptococcus pneumoniae (Spn) during nasopharyngeal colonization.
Methods And Results: Genomic analysis of 128 macrolide-resistant Spn isolates revealed recombination events in genes of the conjugation apparatus, or the competence system, in strains carrying Tn916-related elements. Studies using confocal and electron microscopy demonstrated that during the transfer of Tn916-related elements in nasopharyngeal cell biofilms, pneumococcal strains formed clusters facilitating their acquisition of resistance determinants at a high recombination frequency (rF).
Comparative genomic and morphological analyses of capsular and capsular-deficient pneumococcal strains simultaneously isolated from a patient with invasive pneumococcal disease.
J Infect Chemother
August 2024
Department of Infectious Diseases, Medical Mycology Research Center, Chiba University, Chiba, Japan.
Article Synopsis
- Understanding the in-vivo dynamics of pneumococci is crucial for investigating carriage in patients with invasive pneumococcal disease (IPD).
- This study compared genomic and morphological differences between a capsular strain from blood and a non-capsular strain from sputum in a patient with IPD.
- Findings indicated the blood strain was encapsulated while the sputum strain was non-encapsulated with a higher biofilm-forming capacity, suggesting a potential morphological change in Streptococcus pneumoniae during infection.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!